Back to ranking
#42USNASDAQ

LQDA

Liquidia Corporation

$27.67USD

Data as of 2026-10-14

Fair value$23.50
Target$25.73
Loss chance39%Moderate-low

Company attributes

SizeMid cap
SectorHealth Care
DividendNone
TypeCommon stock

Price

Interactive 5-year price history chart for LQDA. Latest close $27.67.

Loading price history…

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Health Care median (n=163)
  • Quality
    Profit margins & asset efficiency
    84
    Exceptional
    Health Care median (n=163) 51
  • Value
    Price vs fundamentals
    61
    Strong
    Health Care median (n=163) 52
  • Growth
    Revenue & earnings trajectory
    74
    Exceptional
    Health Care median (n=163) 50
  • Momentum
    Recent price strength
    57
    Strong
    Health Care median (n=163) 66
  • Health
    Balance sheet & solvency
    67
    Strong
    Health Care median (n=163) 56
  • Profitability
    ROE, ROA, ROIC
    77
    Exceptional
    Health Care median (n=163) 49
  • Technical
    Trend & volatility signals
    29
    Weak
    Health Care median (n=163) 57
  • Risk
    Volatility & drawdown profile
    41
    Average
    Health Care median (n=163) 47
025405570100
Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Risk Summary

Low
Manipulation index
5/100
Composite penalty: −0.50 pts (informational; rank uses raw composite)
Fired components (1)
  • Accruals momentum (Δ TATA > 0.05 over 3y)[accruals_momentum_high]

Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.

Fair price check

3 different valuation methods each estimate what LQDA should be worth, then we compare to today's price.

Looks overvalued
Models suggest LQDA is trading above fair value
Today's price
$27.67
Median fair price
$23.50
-15% vs today's price
Of 3 methods:1 say fair2 say pricey
  • EV/EBITDAFair
    thinks it's fairly priced — estimates $25.73, about 7% below today
  • P/E multiplesOvervalued
    thinks it's expensive — estimates $23.50, about 15% below today
  • P/B multiplesOvervalued
    thinks it's expensive — estimates $6.12, about 78% below today

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair
$23.50
Margin of safety(vs fair value)
-17.7%
Max (ex-outliers)
$25.73
Tangible BVPS
$2.10
  • Accruals momentum
  • Value-trap risk (RIM)

Median of all applicable methods (current price $27.67). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

MetricValue
Market cap$2.48B
Revenue (TTM)$450.91M
Net income (TTM)$138.61M
Operating cash flow (TTM)$167.71M
CapEx (TTM)$17.01M
Free cash flow (TTM)CFO − CapEx$150.69M
Total assets$521.92M
Total liabilities$326.80M
Stockholders' equity$195.11M
Cash & equivalents$284.18M
Shares outstanding89.51M
EPS (basic)$1.55
EPS (diluted)$1.55
P/E ratio (TTM)17.87

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date
2026-08-12
Latest period end
2026-07-29
Filing lag
63 days
Missing metrics
3(gross_profit, cost_of_revenue, dividends_paid)

Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.